Sellwell Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
- Paid Up Capital ₹ 5.57 M
- Company Age 35 Year, 5 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 4.72 Cr
- Satisfied Charges ₹ 3.36 Cr
- Revenue Growth 17.83%
- Profit Growth 26.79%
- Ebitda 1.95%
- Net Worth 9.21%
- Total Assets 22.65%
About Sellwell Pharmaceuticals
Sellwell Pharmaceuticals Limited (SPL) is a leading Public Limited Indian Non-Government Company incorporated in India on 14 August 1989 and has a history of 35 years and five months. Its registered office is in Na, Madhya Pradesh.
The Corporate was formerly known as Sellwell Pharmaceuticals Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 5.57 M.
The company currently has active open charges totaling ₹4.72 Cr. The company has closed loans amounting to ₹3.36 Cr, as per Ministry of Corporate Affairs (MCA) records.
Kamal Karamchandani, Muskan Karamchandani, and Harish Matlani serve as directors at the Company.
Company Details
-
LocationNa, Madhya Pradesh
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24232MP1989PLC005424
-
Company No.
005424
-
Company Classification
Public Limited Indian Non-Government Company
-
Incorporation Date
14 Aug 1989
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Gwalior
Industry
Who are the key members and board of directors at Sellwell Pharmaceuticals?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Kamal Karamchandani
|
Managing Director | 23-Mar-2012 | Current |
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
|
Muskan Karamchandani
|
Director | 23-Mar-2012 | Current |
|
Harish Matlani
|
Director | 28-Mar-2019 | Current |
Financial Performance of Sellwell Pharmaceuticals.
Sellwell Pharmaceuticals Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 17.83% increase. The company also saw a substantial improvement in profitability, with a 26.79% increase in profit. The company's net worth moved up by a moderate rise of 9.21%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Sellwell Pharmaceuticals?
In 2022, Sellwell Pharmaceuticals had a promoter holding of 99.91% and a public holding of 0.09%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹4.72 Cr
₹3.36 Cr
Charges Breakdown by Lending Institutions
- Axis Bank Limited : 4.72 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 02 Jul 2024 | Axis Bank Limited | ₹0.43 M | Open |
| 28 Jun 2021 | Axis Bank Limited | ₹1.28 M | Open |
| 28 Nov 2016 | Axis Bank Limited | ₹4.55 Cr | Open |
| 27 May 2016 | Others | ₹2.50 M | Satisfied |
| 06 Jan 2015 | Cosmos Co-Operative Bank Ltd. | ₹1.30 M | Satisfied |
How Many Employees Work at Sellwell Pharmaceuticals?
Sellwell Pharmaceuticals has a workforce of 31 employees as of Mar 31, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sellwell Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sellwell Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
